老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

24.53
+0.34001.41%
盤後：24.530.00000.00%19:31 EDT
成交量：115.86萬
成交額：2,842.14萬
市值：30.43億
市盈率：-193.36
高：24.80
開：24.76
低：24.24
收：24.19
52周最高：31.77
52周最低：12.42
股本：1.24億
流通股本：8,824.23萬
量比：1.16
換手率：1.31%
股息：- -
股息率：- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
淨資產收益率：-9.30%
總資產收益率：-1.95%
市淨率：16.06
市盈率(LYR):-193.36

資料載入中...

總覽公司新聞資訊公告
2020/09/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/29

重要事件披露

8-K - Current report
2020/09/18

重要事件披露

8-K - Current report
2020/09/09

重要事件披露

8-K - Current report
2020/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report
2020/07/31

重要事件披露

8-K - Current report
2020/07/29

重要事件披露

8-K - Current report
2020/05/13

重要事件披露

8-K - Current report
2020/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/29

重要事件披露

Current report, item 1.01
2020/04/27

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2020/03/19

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/10

超過5%披露

General statement of acquisition of beneficial ownership
2020/02/10

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

General statement of acquisition of beneficial ownership
2020/02/07

超過5%披露

General statement of acquisition of beneficial ownership
2020/01/31

員工持股計劃

Securities to be offered to employees in employee benefit plans
更多